CDEK
← All organizations

On Target Laboratories, LLC

For profitContributed to NMEWebsite ↗

Also known as: On Target Laboratories, LLC | ON TARGET LABS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Dec 1, 2014

First marketed drug

Nov 29, 2021

First NDA

Nov 29, 2021

Last known activity

Apr 2, 2025

Timeline

2010s

  1. Jun 1, 2010

    On Target Laboratories, LLC— Founded

2020s

  1. Nov 29, 2021

    pacritinib— Marketing Organization

  2. Nov 29, 2021

    pacritinib— NDA Organization

  3. Nov 29, 2021

    pacritinib— NDA Secondary Org

Drugs by trial phase (2 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (6)

Details

Founded
Northbrook, IL, US Jun 1, 2010
First NDA
Nov 29, 2021
Last known activity
Apr 2, 2025

Designations held

  • Orphan drug
  • Fast track
  • Priority review
  • Accelerated approval